ClinicalTrials.Veeva

Menu

The Vascular and Cognitive Effects of Chronic High-flavanol Intake in Healthy Males

University of Reading logo

University of Reading

Status

Unknown

Conditions

Healthy

Treatments

Dietary Supplement: Low-flavanol milk chocolate
Dietary Supplement: High-flavanol milk choocolate

Study type

Interventional

Funder types

Other

Identifiers

NCT02789761
MCStudy

Details and patient eligibility

About

A randomised, placebo-controlled, parallel human dietary intervention trial conducted in 33 healthy males to investigate the vascular and cognitive effects of bi-daily consumption of high-flavanol (epicatechin-rich) milk chocolate over a 2-week intervention period. Subjects visited the Hugh Sinclair Unit of Human Nutrition on 3 separate occasions; at the beginning, end and post-intervention.

Enrollment

34 patients

Sex

Male

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Body Mass Index 18.5-27.5 kg/m2
  • Normal Blood pressure (< 150/90)
  • Non-smoker
  • Regular exercise routine
  • Signed consent form

Exclusion Criteria:

  • Haemoglobin (anaemia marker) < 125 g/l
  • Gamma GT (liver enzymes) > 80 IU/l
  • Total Cholesterol > 6.5 mmol/l
  • Suffered a myocardial infarction or stroke in the last 12 months
  • Suffers from any cardiovascular or metabolic disorders
  • Suffers from any blood-clotting disorder, and/or takes supporting medication
  • Any dietary restrictions or on a weight reducing diet
  • On any lipid-modifying or blood pressure lowering medication
  • Consuming any specific vitamin/ herbal supplements or fish oils

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

34 participants in 2 patient groups, including a placebo group

High-flavanol milk chocolate
Active Comparator group
Description:
Bi-daily consumption of 12 g portion of a high-flavanol milk chocolate containing approximately 35 mg of (-)-epicatechin for 2-weeks (14 days)
Treatment:
Dietary Supplement: High-flavanol milk choocolate
Low-flavanol milk chocolate
Placebo Comparator group
Description:
Bi-daily consumption of 12 g portion of a low-flavanol milk chocolate containing approximately \<1 mg of (-)-epicatechin for 2-weeks (14 days)
Treatment:
Dietary Supplement: Low-flavanol milk chocolate

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems